Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report

Overview of attention for article published in Frontiers in oncology, July 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,305 followers.

New research: Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report: Background: Merkel-cell carcinoma (MCC) is a… https://t.co/v

11 Aug 2020

Reply Repost Favourite

Somatostatin receptors in Merkel-cell carcinoma: a therapeutic opportunity using somatostatin analogue alone or in association with checkpoint inhibitors immunotherapy. A case report https://t.co/SJKBlyQ0gm

30 May 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.